BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home » Blogs » BioWorld MedTech Perspectives » Augmented reality check

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology

Augmented reality check

Aug. 16, 2017
By Omar Ford

OpenSight Press 1

My first real exposure to what's commonly called augmented reality was about a year ago when one of my former colleagues introduced me to Pokemon Go. I remember her telling me that you could actually hold up your smartphone or tablet and see actual Pokemon along the street.

Now fast forward by a year, and most of the hype surrounding the game has waned off. However there is still tremendous enthusiasm with augmented reality. In fact reality altering technology isn't just regulated to Pokemon and the video gaming industry, it has invaded health care and looks to be more than a fad.

Recently, I had the pleasure of interviewing Neuroradiologist Wendell Gibby, who has found a way to insert augmented reality into an automated percutaneous lumbar discectomy (APLD) procedure for disk herniation. Gibby founded in Novarad Corp. which has developed the Opensight software to be used in conjunction with Microsoft Corp.'s Hololens technology.

When I talked to him you could just hear the excitement in his voice. This veteran Neuroradiologist was literally blown away by what Opensight and the Hololens could do.

In the APLD procedure, an image of the patient's spine was taken with CT, then loaded onto the Opensight software. From there the image was transferred through the cloud to the Hololens, which was worn by Gibby. That image was then projected onto the patient's body while Gibby did the procedure.

Just imagine the impact this could have on other procedures once it becomes tested and perfected, Gibby said. He kept repeating, the ability to look at the inside of the body on the surface of the patient is incredible!

"I could never have imagined this in my wildest dreams," Gibby said.

Augmented reality is quickly taking root into the health care space, offering enhanced imaging and easier surgical procedures. During the 2016 Cleveland Clinic Medical Innovation summit, augmented reality for surgery made the top 10 list for medical innovations.

This innovation, which emerged from the same technology that fueled the gaming industry, offers surgeons – especially those conducting neurosurgery and retinal microsurgery – the opportunity to better identify tissue structures, said Rishi Singh, of the Clinic's Cole Eye Institute, who noted that his experience with the technique "felt ergonomically better."

Augmented reality can be a useful tool in health care. I don't think this is a fad, but rather the start of something big. But most importantly it's getting physicians and surgeons to dream again.

 

 

 

 

 

 

 

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Amyloid beta peptides on neurons

    Amlogenyx’s AM-805 reduces amyloid plaques in AD

    BioWorld Science
    The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Atai Therapeutics patents new 5-HT2 receptor agonists

    BioWorld Science
    Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing